3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Philadelphia Chromosome
2
Ovarian Neoplasms
2
Neoplasms
2
Recurrence
1
Peritoneal Neoplasms
1
Neoplasm Metastasis
1
Myeloproliferative Disorders
1
Leukemia
1
Genital Neoplasms, Female
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Breast Neoplasms
1
Appendiceal Neoplasms
1
Interventions
zanubrutinib
1
ruxolitinib
1
pirtobrutinib
1
idecabtagene vicleucel
1
ibrutinib
1
fludarabine
1
acalabrutinib
1
Leukapheresis
1
Lenalidomide
1
Cyclophosphamide
1
CPI-0610
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hematologic Diseases
×
nilotinib
×
30 days
×
Clear all
No trials found.